• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9553
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Unspecified Heart Problem (4454)
Event Date 09/04/2023
Event Type  Death  
Manufacturer Narrative
E1 - initial reporter facility name: (b)(6) hospital.E1 - initial reporter phone: (b)(6).
 
Event Description
Promus premier china registry.It was reported that the patient died.In (b)(6) 2018, the index procedure was performed.The target lesion was located in the middle right coronary (rca) artery extending up to distal rca with 90% stenosis and was 10 mm long, with a reference vessel diameter of 2.5mm.The target lesion was treated with pre-dilatation and placement of 2.50 mm x 12 mm promus premier stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Eight days later, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2023, the subject died.No action was taken to treat the event and the primary cause of death is unknown.It is unknown if an autopsy was performed.It was further reported that the primary cause of death is myocardial infarction.
 
Manufacturer Narrative
E1 - initial reporter facility name: (b)(6).E1 - initial reporter phone: (b)(6).
 
Event Description
Promus premier china registry.It was reported that the patient died.In (b)(6) 2018, the index procedure was performed.The target lesion was located in the middle right coronary (rca) artery extending up to distal rca with 90% stenosis and was 10 mm long, with a reference vessel diameter of 2.5mm.The target lesion was treated with pre-dilatation and placement of 2.50 mm x 12 mm promus premier stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Eight days later, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2023, the subject died.No action was taken to treat the event and the primary cause of death is unknown.It is unknown if an autopsy was performed.It was further reported that the primary cause of death is acute myocardial infarction (mi).The location of the mi was anterior (septal).It was further reported that a 2.5 mm x 32 mm promus premier stent was implanted at the index procedure in (b)(6) 2018.It was further reported that the patient died, and the primary cause of death is cardiogenic.
 
Manufacturer Narrative
E1 - initial reporter facility name: (b)(6) university.E1 - initial reporter phone: (b)(6).
 
Event Description
Promus premier china registry it was reported that the patient died.In september 2018, the index procedure was performed.The target lesion was located in the middle right coronary (rca) artery extending up to distal rca with 90% stenosis and was 10 mm long, with a reference vessel diameter of 2.5mm.The target lesion was treated with pre-dilatation and placement of 2.50 mm x 12 mm promus premier stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Eight days later, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2023, the subject died.No action was taken to treat the event and the primary cause of death is unknown.It is unknown if an autopsy was performed.It was further reported that the primary cause of death is acute myocardial infarction (mi).The location of the mi was anterior (septal).It was further reported that a 2.5 mm x 32 mm promus premier stent was implanted at the index procedure in (b)(6) 2018.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17980708
MDR Text Key326232506
Report Number2124215-2023-57019
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/04/2020
Device Model Number9553
Device Catalogue Number9553
Device Lot Number0021601218
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/04/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age62 YR
Patient SexMale
-
-